Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for fatigue and other symptoms in patients with advanced cancer
2008-008377-56Phase 3Completed
- Sponsor
- Palliativ medicinsk afdeling, Bispebjerg Hospital
- Start
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in asthenia, sleep disorder, anorexia nervosa (AN) and 3 more comparing Melatonin with Placebo (2 arms). Primary endpoint: Fatigue. Started Jan 2009; status: completed.
02
Drugs
melatonin
03
Conditions
astheniasleep disorderanorexia nervosa (AN)major depressive disorder (MDD)pain
Beyond the preview
Go deeper on 2008-008377-56.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-008377-56.